Previous 10 | Next 10 |
home / stock / npth:cc / npth:cc news
Received binding offer to purchase London medical facility, closing August 1, 2023 Two London clinics to be co-located in a newer facility to better serve our patients Net proceeds will further reduce debt, eliminating mortgage on the medical facility Annualized operating ...
NeuPath is the largest provider of comprehensive pain management in Canada As a private provider to the public healthcare system, NeuPath is well positioned to assist the public sector and provide enhanced service to patients Organic and acquisition opportunities are under review ...
Delivered strong third quarter revenues of $15.2 million including non-clinic revenues of $1.0 million Adjusted EBITDA (1) of $0.4 million, our 15 th consecutive quarter of positive adjusted EBITDA New fluoroscopy suite opened in Ottawa and new physicians add...
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced updates to the Company’s Board of Directors that will continue to support the ...
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today provided an update on leadership changes, as well as its strategic growth plan to significantly...
Delivered record quarterly total revenues of $15.9 million and record quarterly non-clinic revenues of $1.0 million in the second quarter of 2022 Adjusted EBITDA (1) was in line with the comparative three-month period, and increased by 140% quarter-over-quarter to $0.8 m...
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced it has entered into a consulting agreement with one of the Company’s directors...
NeuPath is the largest provider of comprehensive pain management in Canada The market is highly fragmented and coordinated care remains elusive to many patients NeuPath has the opportunity to be the largest, best-in-class provider of a continuum of coordinated care f...
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced the voting results from its Annual General and Special Meeting of Shareholders (the &...
Total revenue increased by 9% to $15.4 million in the quarter Non-clinic revenue increased by 45% to $0.9 million in the quarter 13 th consecutive quarter of positive adjusted EBITDA (1) Fueling future growth with completion of three new fluoroscopy s...
News, Short Squeeze, Breakout and More Instantly...
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced the voting results from its Annual General and Special Meeting of Shareholders (the “Mee...
Delivered record first quarter total revenue of $17.5 million, up 9% year-over-year Adjusted EBITDA (1) of $0.9 million, our 21 st consecutive quarter of positive adjusted EBITDA Improved cash flows, closing cash and cash equivalents balance of $2.6 million, up more than 3...
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced that Joseph Walewicz, CEO, will be presenting at the 2024 Bloom Burton & Co. Healthcare Inv...